A pilot study of the safety, efficacy, and tolerability of ezetimibe (Zetia) in combination with statin therapy for the treatment of elevated LDL cholesterol in HIV-infected subjects

Trial Profile

A pilot study of the safety, efficacy, and tolerability of ezetimibe (Zetia) in combination with statin therapy for the treatment of elevated LDL cholesterol in HIV-infected subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Oct 2012

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Oct 2009 Results published in AIDS.
    • 08 Feb 2009 Results reported at the 16th Conference on Retroviruses and Opportunistic Infections.
    • 08 Feb 2009 Primary endpoint 'Low density lipoprotein cholesterol level' has been met according to results presented at the 16th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top